Novavax's potential vaccine to prevent Covid-19 generated a promising immune response in an early-stage clinical trial, the U.S.-based biotech firm announced Tuesday.
generated a promising immune response in an early-stage clinical trial, the U.S.-based biotech firm announced Tuesday.
Participants received two doses of the potential vaccine via intramuscular injection approximately 21 days apart, the company said.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Bollywood Star Amitabh Bachchan Recovers From COVID-19Bollywood superstar Amitabh Bachchan was discharged from a Mumbai hospital on Sunday after undergoing three weeks of treatment for the coronavirus
続きを読む »
COVID-19 outbreak occurs on Norway cruise ship MS Roald Amundsen - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
続きを読む »
At least 40 infected with COVID-19 on Norway cruises amid scramble to trace passengersAt least 40 passengers and crew from a luxury cruise liner have tested positive for COVID-19 and the authorities are still trying to trace a number of passengers from two recent Arctic voyages, public health officials in Norway said on Sunday.
続きを読む »
The COVID-19 Pandemic Has Increased Anxiety and Depression in College Students, a Study FindsA 2020 Dartmouth study shows an unprecedented increase in mental health conditions due to the coronavirus among undergraduate college students.
続きを読む »
College Athletes Threaten To Skip Season Over COVID-19, Racial Justice DemandsPlayers from PAC-12 schools said they will sit out the upcoming football season unless the conference meets their health and racial justice demands.
続きを読む »